Flyover Future HealthTech: IBM & Cleveland Clinic; AlphaLab Health; Possible Cancer therapy
- A gene therapy strategy developed by Mayo Clinic researchers could offer a potential treatment for propionic acidemia, a rare and fatal genetic disease that often sickens babies in their first days of life.
- A new study out of Washington University School of Medicine in St. Louis shows there are important links between human and mouse minds in how they function—and malfunction.
- Researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania were able to reverse blindness in a patient with a rare genetic disorder using RNA therapy.
- Davendra Sohal, MD, a University of Cincinnati researcher and UC Health physician, is leading a national trial for a possible therapy for pancreatic cancer.
- IBM has announced a 10-year partnership with the Cleveland Clinic to establish the “Discovery Accelerator,” a research engine using emerging tech to advance healthcare and life sciences.
- Seven companies have been selected for the inaugural class of AlphaLab Health, a newly created business accelerator launched in Pittsburgh this year. The focus is on supporting health care and life sciences to provide promising health businesses.